KRISTIN SERRATO: Open Payments
NPI 1063914398 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 51 payments from 13 companies in 2025. Trend: 2023 $243 · 2024 $1,327 · 2025 $1,948
Food & beverage: $1,804Education: $144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $535 |
| Janssen Biotech, Inc. | 15 | $516 |
| GENZYME CORPORATION | 4 | $342 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $171 |
| Madrigal Pharmaceuticals | 1 | $136 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| PFIZER INC. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, REZDIFFRA, DUPIXENT, CREON, IQIRVO.
Industry payments across AZ — which companies pay providers there.
